These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16954221)

  • 41. Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody.
    Bian C; Zhang X; Cai X; Zhang L; Chen Z; Zha Y; Xu Y; Xu K; Lu W; Yan L; Yuan J; Feng J; Hao P; Wang Q; Zhao G; Liu G; Zhu X; Shen H; Zheng B; Shen B; Sun B
    Virology; 2009 Jan; 383(1):39-46. PubMed ID: 18986662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors.
    Zhang Y; Zheng N; Nan P; Cao Y; Hasegawa M; Zhong Y
    Comput Biol Chem; 2007 Apr; 31(2):134-7. PubMed ID: 17368104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity.
    He Y; Li J; Jiang S
    Biochem Biophys Res Commun; 2006 May; 344(1):106-13. PubMed ID: 16615996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
    Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
    Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein.
    Zhong L; Haynes L; Struble EB; Tamin A; Virata-Theimer ML; Zhang P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):1056-60. PubMed ID: 19861118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
    Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
    Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
    Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM
    Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.
    Zhou Y; Lu K; Pfefferle S; Bertram S; Glowacka I; Drosten C; Pöhlmann S; Simmons G
    J Virol; 2010 Sep; 84(17):8753-64. PubMed ID: 20573835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
    Miyoshi-Akiyama T; Ishida I; Fukushi M; Yamaguchi K; Matsuoka Y; Ishihara T; Tsukahara M; Hatakeyama S; Itoh N; Morisawa A; Yoshinaka Y; Yamamoto N; Lianfeng Z; Chuan Q; Kirikae T; Sasazuki T
    J Infect Dis; 2011 Jun; 203(11):1574-81. PubMed ID: 21592986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
    Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
    Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
    Xu Y; Lou Z; Liu Y; Pang H; Tien P; Gao GF; Rao Z
    J Biol Chem; 2004 Nov; 279(47):49414-9. PubMed ID: 15345712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2.
    Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C
    Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
    Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
    Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The spike protein of SARS-CoV--a target for vaccine and therapeutic development.
    Du L; He Y; Zhou Y; Liu S; Zheng BJ; Jiang S
    Nat Rev Microbiol; 2009 Mar; 7(3):226-36. PubMed ID: 19198616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
    Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
    J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.
    Rockx B; Corti D; Donaldson E; Sheahan T; Stadler K; Lanzavecchia A; Baric R
    J Virol; 2008 Apr; 82(7):3220-35. PubMed ID: 18199635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.
    Wang S; Chou TH; Sakhatskyy PV; Huang S; Lawrence JM; Cao H; Huang X; Lu S
    J Virol; 2005 Feb; 79(3):1906-10. PubMed ID: 15650214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.
    Wong SK; Li W; Moore MJ; Choe H; Farzan M
    J Biol Chem; 2004 Jan; 279(5):3197-201. PubMed ID: 14670965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion.
    Beniac DR; deVarennes SL; Andonov A; He R; Booth TF
    PLoS One; 2007 Oct; 2(10):e1082. PubMed ID: 17957264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.